Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation

Author: Wuthrich R.P.   Weinreich T.   Schwarzkopf A.K.   Candinas D.   Binswanger U.  

Publisher: Elsevier

ISSN: 0041-1345

Source: Transplantation Proceedings, Vol.30, Iss.8, 1998-12, pp. : 4096-4097

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content